Alidad Mireskandari

SVP, Business Development at Interpace Biosciences

Alidad Mireskandari brings over 10 years of experience in molecular diagnostics and genetic testing to Interpace Biosciences. He has experience in product development, regulatory assurance, business development and reimbursement; and has led the development and commercialization of a number of diagnostic products on multiple technology platforms. Prior to joining Interpace, Mr. Mireskandari was President & CEO of JS Genetics, a start-up company, overseeing the introduction of 3 products to market using technologies licensed from Yale University. Mr. Mireskandari also managed R&D activities and built operational capabilities of commercial laboratory to include CLIA license certification, CAP accreditation and NY state licensure. From 2000-2009, Mr. Mireskandari was a Hedge Fund Manager in charge of Life Sciences trading portfolios of Nomura Securities, BNP Paribas and Raeburn Advisors. Prior to that Mireskandari was research fellow at NIH’s Nation Cancer Institute in Bethesda MD.


  • SVP, Business Development

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.